Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with11C-raclopride and positron emission tomography-Reference-Cited by-同舟云学术

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with11C-raclopride and positron emission tomography

Published:1992-02 Issue:2 Volume:31 Page:184-192
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Brooks D. J.,Ibanez V.,Sawle G. V.,Playford E. D.,Quinn N.,Mathias C. J.,Lees A. J.,Marsden C. D.,Bannister R.,Frackowiak R. S. J.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference49 articles.

1. THE INCIDENCE AND CHARACTERISTICS OF LEWY BODIES IN IDIOPATHIC PARALYSIS AGITANS (PARKINSON'S DISEASE)

2. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy

3. SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE

4. Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

5. Neurotransmitter receptor alterations in Parkinson's disease

Cited by 389 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2024-04

2. Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism;Neural Regeneration Research;2023-12-21

3. Dopamine, Immunity, and Disease;Pharmacological Reviews;2022-12-08

4. Soft Attention Based DenseNet Model for Parkinson’s Disease Classification Using SPECT Images;Frontiers in Aging Neuroscience;2022-07-13

5. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool;Journal of Neurochemistry;2022-01-09